India Glycols wins over Rs 1,200 crore orders from OMCs; should you buy/sell smallcap stock?

India Glycols Limited Share Price News: Should you buy, sell or hold the India Glycols Ltd stock now? Noida-based sustainable chemical maker India Glocols Ltd—whose shares trade with the symbol INDIAGLYCO on stock exchanges BSE and NSE—has attracted market participants’ attention on Dalal Street. India Glycols recently won a Rs 1,227-crore order from state-run oil marketing companies (OMCs) Bharat Petroleum Corporation Ltd, Indian Oil Corporation Ltd and Hindustan Petroleum Corporation Ltd. Many analysts have positive views on the smallcap chemical stock, which has declined about 9 per cent so far in 2025 but has grown more than 33 per cent in the past one year.

Read on to learn about the INDIAGLYCO stock in detail:

India Glycols Limited (INDIAGLYCO) Share Price Movement

Add Zee Business as a Preferred Source

As of February 19, India Glycols shares, which entered the listed space almost 20 years ago, have gyrated in a Rs 429 range—between Rs 1,046 and Rs 1,475—in intraday year so far this year.

The smallcap stock is down 7.2 per cent on a year-to-date basis.

In the past one year, it has delivered a return of more than 33 per cent to investors.

On Thursday, the stock gained by Rs 10.3, or 0.9 per cent, to end at Rs 1,169.1 apiece on BSE. During the session, the smallca stock gained as much as 5.7 per cent to trade within Rs 320 of its all-time high, recorded in October last year.

How analysts view India Glycols stock

According to analysts at SBI Securities, the winning of ethanol supply orders, amounting to Rs 1,264 crore from OMCs and oil companies, is positive for India Glycols for the long term.

Analysts at Nuvama expect India Glycols to maintain CAGRs of 15 per cent, 13 per cent and 24 per cent in revenue, EBITDA and net profit over the four-year period ending March 2027, according to a research report dated February 10.

The company staged a strong financial performance for the October-December period, driven by growth in its biofuels and potable spirit unit.

Nuvama has a ‘buy’ rating on India Glycols with a target price of Rs 1,580, valuing the company at an embedded value-to-EBITDA multiple of 8.0 times.

India Glycols vs Peers

Here's how India Glycols has performed among some of its peers:

India Glycols Q3 FY25 Results Summary

Earlier this month, India Glycols reported a 36.5 per cent jump in its consolidated net profit to Rs 56.8 crore for the quarter ended December 31.

Its quarterly revenue grew 14.4 per cent to Rs 2,424 crore while EBITDA increased 21.2 per cent to Rs 129.5 crore, according to a regulatory filing.

What does India Glycols do?

India Glycols produces a range of products including green technology-based bulk, specialty and performance chemicals. It also manufactures natural gums, spirits, industrial gases, sugar and nutraceuticals.

Catch key stock market updates here. For all other news, visit Zeebiz.com.